KRISTEN MASTER: Open Payments
NPI 1427590819 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 45 payments from 26 companies in 2025. Trend: 2023 $21 · 2024 $373 · 2025 $1,087
Food & beverage: $988Education: $99
| Company | Payments | Amount |
|---|---|---|
| TerSera Therapeutics LLC | 4 | $126 |
| Aveo Pharmaceuticals, Inc. | 2 | $118 |
| Daiichi Sankyo Inc. | 5 | $110 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| ABBVIE INC. | 2 | $50 |
| Janssen Biotech, Inc. | 3 | $49 |
| Celgene Corporation | 2 | $48 |
| GENZYME CORPORATION | 2 | $45 |
| Menarini Silicon Biosystems, Inc. | 1 | $41 |
| EMD Serono, Inc. | 2 | $40 |
Products named: FOTIVDA, Zoladex, OPDIVO, Enhertu, Xermelo, Cellsearch, LUTATHERA, RYBREVANT.
Industry payments across IN — which companies pay providers there.
